Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > does anyone see this stock hitting $8.00 in the future?

<< Previous

Bullboard Posts

Next >>

Comment by FriedChickenon Feb 03, 2021 10:52am

128 Views

Post# 32457951

RE:RE:RE:RE:RE:RE:RE:does anyone see this stock hitting $8.00 in the future?

Your complaining about the NEO listing being conditionally granted prior to getting listed on the LSE (while the LSE application, filed a month or so ago, is still under the normal review process) kinda makes your credibility suspect, no?

Tell you what, you get your facts straight about uplisting, and we'll chat, al'rite? Until then, sit back and watch us make money.

Cheers,
FC

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market